Predictions
Inventiva SA
Start price
Target price
Perf. (%)
€11.54
10.09.21
10.09.21
€8.00
10.09.22
10.09.22
-63.65%
11.09.22
11.09.22
Could be worthwhile Investment >10% per year
Inventiva SA
Start price
Target price
Perf. (%)
€2.18
10.09.21
10.09.21
€12.00
-
10.09.21
10.09.21
Could be worthwhile Investment >10% per year
Inventiva SA
Start price
Target price
Perf. (%)
€2.18
10.09.21
10.09.21
€8.00
-
10.09.21
10.09.21
Could be worthwhile Investment >10% per year
Bone Therapeutics S.A.
Start price
Target price
Perf. (%)
€1.56
10.09.21
10.09.21
€2.00
10.09.22
10.09.22
-82.43%
02.06.22
02.06.22
Could be worthwhile Investment >10% per year
Catalyst Biosciences Inc
Start price
Target price
Perf. (%)
€2.07
10.09.21
10.09.21
€3.50
31.12.23
31.12.23
-91.67%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
MacroGenics Inc.
Start price
Target price
Perf. (%)
€19.47
09.09.21
09.09.21
€25.00
31.12.23
31.12.23
-67.12%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
PerkinElmer Inc.
Start price
Target price
Perf. (%)
€160.00
09.09.21
09.09.21
-
09.09.22
09.09.22
-2.97%
10.03.22
10.03.22
Growths faster than the competition
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€7.15
09.09.21
09.09.21
€10.00
31.12.23
31.12.23
-75.78%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€3.44
08.09.21
08.09.21
-
08.09.22
08.09.22
-34.88%
08.12.21
08.12.21
Could be worthwhile Investment >10% per year
MacroGenics Inc.
Start price
Target price
Perf. (%)
€17.00
07.09.21
07.09.21
€15.00
31.12.23
31.12.23
14.50%
09.09.21
09.09.21
Could be very worthwhile Investment >20% year
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€85.80
07.09.21
07.09.21
€110.00
31.12.23
31.12.23
24.13%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
Thermo Fisher Scientific Inc.
Start price
Target price
Perf. (%)
€476.00
07.09.21
07.09.21
€550.00
31.12.23
31.12.23
4.08%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Ziopharm Oncology
Start price
Target price
Perf. (%)
€1.99
07.09.21
07.09.21
€4.00
31.12.23
31.12.23
52.84%
01.09.22
01.09.22
Could be worthwhile Investment >10% per year
Poxel S.A.
Start price
Target price
Perf. (%)
€6.46
06.09.21
06.09.21
€5.00
06.09.22
06.09.22
-9.30%
07.10.21
07.10.21
Could be worthwhile Investment >10% per year
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€55.00
06.09.21
06.09.21
€120.00
31.12.23
31.12.23
-43.27%
10.09.21
10.09.21
Could be very worthwhile Investment >20% year
ShockWave Medical Inc
Start price
Target price
Perf. (%)
€200.00
06.09.21
06.09.21
€300.00
31.12.23
31.12.23
49.10%
01.09.22
01.09.22
Could be very worthwhile Investment >20% year
Editas Medicine Inc
Start price
Target price
Perf. (%)
€58.60
05.09.21
05.09.21
€70.00
05.09.22
05.09.22
-8.43%
18.09.21
18.09.21
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Good rating
Very low/no dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€212.55
05.09.21
05.09.21
€333.00
05.09.22
05.09.22
-85.70%
06.09.22
06.09.22
Top 10 in its market
Could be worthwhile Investment >10% per year
Leading role in innovation
Very Future proof/growth oriented business model
Quoin Pharmaceuticals Ltd. ADR
Start price
Target price
Perf. (%)
€275.00
05.09.21
05.09.21
-
05.09.22
05.09.22
-98.89%
03.09.22
03.09.22
Risky Investment
Innate Pharma
Start price
Target price
Perf. (%)
€4.80
05.09.21
05.09.21
-
05.09.22
05.09.22
-47.79%
07.03.22
07.03.22
Probably not worthwhile Investment
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€4.42
04.09.21
04.09.21
€2.00
04.09.22
04.09.22
-33.48%
18.09.21
18.09.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
Innate Pharma
Start price
Target price
Perf. (%)
€6.20
03.09.21
03.09.21
-
03.09.22
03.09.22
-25.29%
06.09.21
06.09.21
Risky Investment
Valneva SE
Start price
Target price
Perf. (%)
€20.18
03.09.21
03.09.21
€30.00
03.09.22
03.09.22
-59.38%
03.09.22
03.09.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Some uniques
Higher risks for its business